321 related articles for article (PubMed ID: 22745786)
1. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
Coso S; Zeng Y; Opeskin K; Williams ED
PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
[TBL] [Abstract][Full Text] [Related]
2. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
3. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE
Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522
[TBL] [Abstract][Full Text] [Related]
4. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
5. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
6. Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.
Korhonen EA; Murtomäki A; Jha SK; Anisimov A; Pink A; Zhang Y; Stritt S; Liaqat I; Stanczuk L; Alderfer L; Sun Z; Kapiainen E; Singh A; Sultan I; Lantta A; Leppänen VM; Eklund L; He Y; Augustin HG; Vaahtomeri K; Saharinen P; Mäkinen T; Alitalo K
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35763346
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.
Luo Y; Chen W; Zhou H; Liu L; Shen T; Alexander JS; Zheng S; Lu Y; Huang S
Cancer Prev Res (Phila); 2011 Dec; 4(12):2083-91. PubMed ID: 21881029
[TBL] [Abstract][Full Text] [Related]
8. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
9. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
10. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells.
Sakima M; Hayashi H; Mamun AA; Sato M
Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427
[TBL] [Abstract][Full Text] [Related]
11. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
12. Twist modulates lymphangiogenesis and correlates with lymph node metastasis in supraglottic carcinoma.
Lu SM; Yu L; Tian JJ; Ma JK; Li JF; Xu W; Wang HB
Chin Med J (Engl); 2011 May; 124(10):1483-7. PubMed ID: 21740802
[TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis.
Shin JW; Huggenberger R; Detmar M
Blood; 2008 Sep; 112(6):2318-26. PubMed ID: 18614759
[TBL] [Abstract][Full Text] [Related]
15. Essential role of Apelin signaling during lymphatic development in zebrafish.
Kim JD; Kang Y; Kim J; Papangeli I; Kang H; Wu J; Park H; Nadelmann E; Rockson SG; Chun HJ; Jin SW
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):338-45. PubMed ID: 24311379
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
Grummer MA; Sullivan JA; Magness RR; Bird IM
Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
18. Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells.
Kim YM; Namkoong S; Yun YG; Hong HD; Lee YC; Ha KS; Lee H; Kwon HJ; Kwon YG; Kim YM
Biol Pharm Bull; 2007 Sep; 30(9):1674-9. PubMed ID: 17827719
[TBL] [Abstract][Full Text] [Related]
19. The β
Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
[TBL] [Abstract][Full Text] [Related]
20. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]